Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan

Headache

Volumn 42, Issue SUPPL. 1, 2002, Pages 38-43

  Wang, Joseph T ^a   Barr, Charles E ^a   Goldfarb, Scott D ^a  

^a PFIZER INC   (United States)

Author keywords

Adverse events; Almotriptan; Chest pain; Cost; Migraine; Triptans

Indexed keywords

ALMOTRIPTAN; SUMATRIPTAN;

CONFERENCE PAPER; COST CONTROL; DRUG COST; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PRIORITY JOURNAL; THORAX PAIN;

EID: 0036169231     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.0420s1038.x     Document Type: Conference Paper

References (27)

1. B/1D agonists: Insights into migraine pathophysiology using rizatriptan
2. Ergotamine in the acute treatment of migraine: A review and European consensus
3. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
4. Almotriptan is an effective and well-tolerated treatment for migraine pain: Results of a randomised, double-blind, placebo-controlled clinical trial
5. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: A double-blind, randomized, parallel-group, optimumdose comparison
6. Hemodynamic and electrocardiographic effects of almotriptan in healthy volunteers
7. Sumatriptan. An updated review of its use in migraine
8. B/1D agonists - Is there a cause for concern?
9. Zolmitriptan: A review of its use in migraine
10. Adverse reactions attributed to sumatriptan. A postmarketing study in general practice
11. Rizatriptan: A review of its efficacy in the management of migraine
12. Migraine
13. Cardiac risk factors and the use of triptans: A survey study
14. Tolerability of sumatriptan: Clinical trials and post-marketing experience
15. Characteristics and determinants of sumatriptan-associated chest pain
16. Sumatriptan injection and tablets in clinical practice: Results of a survey of 707 migraineurs
17. Chest symptoms after sumatriptan: A two-year clinical practice review in 735 consecutive migraine patients
18. Vasospasminduced myocardial infarction with sumatriptan
19. Tolerability and efficacy of almotriptan in the long-term reatment of migraine
20. Oral almotriptan in the treatment of migraine: Safety and tolerability
21. Burden of migraine in the United States: Disability and economic costs
22. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
23. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy
24. Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: A comparative review
25. Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine
26. A long-term open-label efficacy and safety study of 12.5 mg oral almotriptan in migraine patients
27. American Migraine Study II. Prevalence, burden and health care utilization for migraine in the United States